Comparative study of RT23 and IC-65 tuberculins tested on children with tuberculosis

Irina Ulea1, Gheorghe Murgoci, Mircea Loan Popa

  • 1National Institute of Research-Development for Microbiology and Immunology "Cantacuzino", Bucharest, Romania.

Insights

This study compared two tuberculins, RT23 and IC-65, in children with tuberculosis. Both tuberculin skin test reagents demonstrated equivalent biological potency and high sensitivity for diagnosing tuberculosis.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculosis (TB) diagnosis relies on accurate tuberculin skin testing (TST).
  • Comparing the biological potency of different tuberculin reagents is crucial for reliable TB screening.
  • RT23 and IC-65 are commercially available purified protein derivative (PPD) tuberculins used in TB diagnostics.

Purpose of the Study:

  • To evaluate and compare the biological potency of two tuberculin reagents, RT23 and IC-65.
  • To assess the efficacy and sensitivity of RT23 and IC-65 in diagnosing tuberculosis in children.

Main Methods:

  • A comparative study involving 89 children with confirmed tuberculosis.
  • Simultaneous administration of RT23 and IC-65 tuberculins using the Mantoux method at a concentration of 2 tuberculin units (TU)/0.1 ml.
  • Measurement and statistical analysis of tuberculin skin test reaction sizes.

Main Results:

  • Tuberculin skin test reactions for RT23 ranged from 8-18 mm (mean 12.8 mm), and for IC-65 ranged from 8-18 mm (mean 13.1 mm).
  • No statistically significant difference was found in the mean reaction sizes between RT23 and IC-65 (P=0.3).
  • Both tuberculins showed high sensitivity (RT23: 98.9%, IC-65: 97.8%) with a 10 mm cutoff, indicating comparable diagnostic accuracy.

Conclusions:

  • RT23 and IC-65 exhibit equivalent biological potency and efficacy in diagnosing tuberculosis.
  • The findings support the use of both RT23 and IC-65 as reliable reagents for tuberculin skin testing in pediatric TB cases.
  • This study confirms the comparable performance of these two PPD TST reagents.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...